Clinical Trials Logo

Urinary Bladder Diseases clinical trials

View clinical trials related to Urinary Bladder Diseases.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06364865 Not yet recruiting - Acute Cholecystitis Clinical Trials

AE05ML Device for ML Hem-o-lok Polymer Clip Delivery in Laparoscopic Surgical Procedures Observational Registery Study

AE05ML
Start date: May 24, 2024
Phase:
Study type: Observational [Patient Registry]

This clinical registry study aims to evaluate the safety and effectiveness of the AE05ML device for ligating vessels and tissue structures during laparoscopic surgery using Hem-o-lok® Medium Large (ML) polymer clips. The primary objective is to assess the device's safety and performance, with secondary objectives focusing on device performance characteristics and operator feedback.

NCT ID: NCT06185218 Not yet recruiting - Bladder Disease Clinical Trials

Different Injection Site Maps & Intravesical Botulinum Toxin

Start date: April 2024
Phase: N/A
Study type: Interventional

Botulinum toxin injection into the bladder is used in current practice in urological diseases such as overactive bladder or interstitial cystitis. As far as is known, botulinum toxin injection sites have not been clearly defined. In this study, investigators are planning to compare botulinum toxin effectiveness with different injection site maps.

NCT ID: NCT05941884 Not yet recruiting - Clinical trials for Schistosoma Haematobium

Possible Diagnostic Protein Markers in Schistosoma Related Bladder Diseases.

Start date: October 1, 2023
Phase:
Study type: Observational

Schistosomiasis is the second most common parasitic infection affecting humans, endemic in the Middle East, especially Egypt (1), and in 42 African countries (2). There are 5 main species infecting humans: S. mansoni, S. haematobium, S. japonicum, S. intercalatum, and S. mekongi. S. haematobium is responsible for chronic urogenital infections that may cause serious complications (3). Urinary schistosomiasis is mostly borne in rural and agricultural communities, according to WHO (4)

NCT ID: NCT05927870 Not yet recruiting - Clinical trials for Gall Bladder Disease

Ultrasound Guided Percutaneous Cholecystostomy.

Start date: August 1, 2023
Phase: N/A
Study type: Interventional

Surgical cholecystostomy has proven value in the management of both inflammatory and obstructive biliary tract disease

NCT ID: NCT05724277 Not yet recruiting - Clinical trials for Laparoscopic Cholecystectomy

The Effect of Mindfulness Meditation and Virtual Reality on Laparoscopic Cholecystectomy Patients

Start date: April 1, 2023
Phase: N/A
Study type: Interventional

In this study, it is aimed to compare the effects of short-term mindfulness meditation based on Human Caring Theory and virtual reality on patients scheduled for laparoscopic cholecystectomy.

NCT ID: NCT05643963 Not yet recruiting - Diet, Healthy Clinical Trials

The COOKER-BLADDER Trial

Start date: April 2023
Phase: N/A
Study type: Interventional

The goal of this interventional study is to test the influence of food intake with characteristics of the urinary bladder. The main questions it aims to answer are: - How does food intake modify the characteristics of urothelial cells? - Does change of specific diet regimes influence biomarker characteristics in urine? Participants will follow specific diet regime for a given time period. After completion of this period biomarker assessment is performed. Thereafter the participants follow an opposite diet regime for the same time period with identical biomarker assessment at the end. Biomarkers within the participants and between the diet regimes will be compared to investigate the influence of food intake on the urinary bladder.

NCT ID: NCT03981315 Not yet recruiting - Cholelithiasis Clinical Trials

Bile Composition in Healthy and Gallstones Patients

Start date: October 2019
Phase:
Study type: Observational [Patient Registry]

Determine differences between lithogenic and non-lithogenic bile composition.

NCT ID: NCT03533322 Not yet recruiting - Clinical trials for Gall Bladder Disease

Gall Bladder Status Among Children With Chronic Haemolytic Anemia

GBSACWCHA
Start date: October 1, 2018
Phase:
Study type: Observational

Gall bladder status among children with chronic haemolytic anemia attending to Assuit University Children Hospital. Hemolysis is defined as the premature destruction of red blood cells (RBCs) (a shortened RBC life span). Anemia results when the rate of destruction exceeds the capacity of the marrow to produce RBCs. Normal RBC survival time is 110-120 days (half-life: 55-60 days), and thus, approximately 0.85% of the most senescent RBCs are removed and replaced each day. Patients with chronic haemolytic anemia are subjected to many complications of chronic haemolytic anemia e.g anemic heart failure, complications of blood transfusion as hepatitis and AIDS, hypersplenism, haemosiderosis ,among them there is incidence of gallbladder stone formation. This work aims to a) to determine the prevalence of gall bladder diseases among patient with chronic haemolytic anemia. b) to determine the risk factors of gall bladder diseases among patients with chronic haemolytic anemia.